top of page

Cost

Cost per project estimate: €5500

-immunisation up to 3 proteins

- screening method developed for specificity

- VHH antibody repertoire amplified by RT-PCR

- cloned into phage display libraries

- VHH antibodies selected

Possible Output

TBA

Description of service

Single variable domain on a heavy chain (VHH) antibodies, are compact single Ig domains that bind target proteins with high affinity while reducing their conformational heterogeneity, thereby stabilising multi-protein complexes. Their properties mean that VHH antibodies are versatile tools for structural biology.

 

Scientific relevance: VHH antibodies production has several applications relevant to vaccine design:

  • VHH antibodies/protein complexes may be more stable than individual proteins, favouring crystallisation

    for X-ray analysis (including intrinsically disordered proteins)

  • The CDR3 loop of VHH antibodies can extend into small cavities on antigenic surfaces which otherwise are

    difficult to measure or modulate, and VHH antibodies do not compete with classical antibodies that bind

    the same antigen. Some are in development as therapeutic agents.

  • VHH antibody reagents can capture transient protein conformations

  • VHH antibodies can be immuno-labelled for super-resolution imaging, spin-labelled for EPR spectroscopy

    or heavy metal labelled.

  • Small size can be used in NMR methods, can act as NMR invisible probes for dynamic studies of protein

    conformation.

Timeline 

2-4 months*

(longer if re-immunisation is required)

Contact 

Els Pardon, 

+ 32 2 629 19 95 

Els.Pardon@vub.be 

 

Jan Steyaert,

+ 32 2 629 19 31

jan.steyaert@vub.be

​

Lead Scientist

TBA

Publications

Example publications of VHH antibodies use for structural analysis:

 

  • J Struct Biol. 2011 Apr; 174(1): 124–136. doi: 10.1016/j.jsb.2010.10.007 ‘STRUCTURES OF A KEY INTERACTION PROTEIN FROM THE TRYPANOSOMA BRUCEI EDITOSOME IN COMPLEX WITH SINGLE DOMAIN ANTIBODIES.’ Meiting Wu, Young-jun Park, Els Pardon, Stewart Turley, Andrew Hayhurst, Junpeng Deng, Jan Steyaert, and Wim G. J. Hol.

  • Vaccines (Basel). 2019 Sep; 7(3): 77. doi: 10.3390/vaccines7030077 ‘Nanobodies that Neutralize HIV.’ Robin A. Weiss and C. Theo Verrips.

Sample Requirements - input of users

2mg purified protein for immunisation (or cells expressing protein, or genetic vaccination)

Good assay for selecting VHH antibodies with appropriate properties

VHH (single-domain) antibody production

Free 

bottom of page